BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
wockhardt limited stock

WOCKHARDT LIMITED Share Price

1396.95 8.75 (0.63%)
Dec 13 2024 03:30 PM Pharmaceuticals NSE: WOCKPHARMA

WOCKHARDT LIMITED Share Price Update

As of the latest trading session, WOCKHARDT LIMITED share price is currently at 1396.95, which is up by 8.75 from its previous closing. Today, the stock has fluctuated between 1347.15 and 1412.05. Over the past year, WOCKHARDT LIMITED has achieved a return of 245.52 %. In the last month alone, the return has been 17.44 %. Read More...

WOCKHARDT LIMITED Performance

Day Range

Low1347.15 High1412.05
1396.95

52 Week Range

Low 376.45 High 1466.95
1396.95

WOCKHARDT LIMITED Share Price

7506

532300

WOCKPHARMA

img img img img
No Data Available

Open Price

1388.00

Prev. Close

1388.20

Volume (Shares)

456475.00

Total traded value

6376.72

Upper Circuit

1527.00

Lower Circuit

1249.40

Note: The current prices & values are delayed, Login to your account for live updates.

WOCKHARDT LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 20124.48
PE Ratio (TTM) -98.64
Book Value / Share 170.16
Beta 1.20
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -36.00

WOCKHARDT LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 370.00
Operating Expense 417.00
Net Profit -36.00
Net Profit Margin (%) -9.72
Earnings Per Share (EPS) -2.34
EBITDA 60.00
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 352.00
Operating Expense 373.00
Net Profit 6.00
Net Profit Margin (%) 1.70
Earnings Per Share (EPS) 0.39
EBITDA 107.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 355.00
Operating Expense 505.00
Net Profit -126.00
Net Profit Margin (%) -35.49
Earnings Per Share (EPS) -8.71
EBITDA -22.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 288.00
Operating Expense 367.00
Net Profit -74.00
Net Profit Margin (%) -25.69
Earnings Per Share (EPS) -5.14
EBITDA 30.00
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 260.00
Operating Expense 373.00
Net Profit -107.00
Net Profit Margin (%) -41.15
Earnings Per Share (EPS) -7.39
EBITDA -4.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1154.00
Operating Expense 1603.00
Net Profit -422.00
Net Profit Margin (%) -36.56
Earnings Per Share (EPS) -29.27
EBITDA -9.00
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 1072.00
Operating Expense 1417.00
Net Profit -466.00
Net Profit Margin (%) -43.47
Earnings Per Share (EPS) -32.40
EBITDA -98.00
Effective Tax Rate (%) 9.16
Particulars MAR 2022 (Values in Cr)
Revenue 1372.00
Operating Expense 1594.00
Net Profit -140.00
Net Profit Margin (%) -10.20
Earnings Per Share (EPS) -11.62
EBITDA 260.00
Effective Tax Rate (%) 23.91
Particulars MAR 2021 (Values in Cr)
Revenue 987.00
Operating Expense 1509.00
Net Profit 593.00
Net Profit Margin (%) 60.08
Earnings Per Share (EPS) 53.57
EBITDA -239.00
Effective Tax Rate (%) 37.07
Particulars MAR 2020 (Values in Cr)
Revenue 890.06
Operating Expense 1416.76
Net Profit -231.12
Net Profit Margin (%) -25.96
Earnings Per Share (EPS) -20.88
EBITDA -90.12
Effective Tax Rate (%) 32.66
Particulars MAR 2024 (Values in Cr)
Book Value / Share 218.12
ROE % -12.34
ROCE % -0.86
Total Debt to Total Equity 0.68
EBITDA Margin 6.22
Particulars MAR 2023 (Values in Cr)
Book Value / Share 232.92
ROE % -9.21
ROCE % -0.45
Total Debt to Total Equity 0.61
EBITDA Margin 8.45
Particulars MAR 2022 (Values in Cr)
Book Value / Share 267.29
ROE % -3.06
ROCE % 1.15
Total Debt to Total Equity 0.67
EBITDA Margin 9.85
Particulars MAR 2021 (Values in Cr)
Book Value / Share 306.91
ROE % 27.45
ROCE % 13.00
Total Debt to Total Equity 1.03
EBITDA Margin 38.92
Particulars MAR 2020 (Values in Cr)
Book Value / Share 241.26
ROE % -1.62
ROCE % 0.46
Total Debt to Total Equity 1.20
EBITDA Margin 8.87
Particulars MAR 2024 (Values in Cr)
Book Value / Share 116.62
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.17
EBITDA Margin -0.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 121.74
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.02
EBITDA Margin 12.78
Particulars MAR 2022 (Values in Cr)
Book Value / Share 153.61
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.07
EBITDA Margin 18.95
Particulars MAR 2021 (Values in Cr)
Book Value / Share 146.00
ROE % 56.52
ROCE % -7.40
Total Debt to Total Equity 1.71
EBITDA Margin -9.83
Particulars MAR 2020 (Values in Cr)
Book Value / Share 89.82
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.64
EBITDA Margin 0.50
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 124.00
Total Assets 7683.00
Total Liabilities 7683.00
Total Equity 3662.00
Share Outstanding 144060153
Price to Book Ratio 1.26
Return on Assets (%) -7.27
Return on Capital (%) -10.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 406.00
Total Assets 8243.00
Total Liabilities 8243.00
Total Equity 4202.00
Share Outstanding 144060153
Price to Book Ratio 1.72
Return on Assets (%) -2.96
Return on Capital (%) -4.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 292.00
Total Assets 7774.00
Total Liabilities 7774.00
Total Equity 3759.00
Share Outstanding 110781153
Price to Book Ratio 2.84
Return on Assets (%) 8.82
Return on Capital (%) 11.26
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 268.46
Total Assets 8178.91
Total Liabilities 8178.91
Total Equity 3057.46
Share Outstanding 110735003
Price to Book Ratio 1.92
Return on Assets (%) -0.84
Return on Capital (%) -1.33
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 448.65
Total Assets 7844.31
Total Liabilities 7844.31
Total Equity 3004.63
Share Outstanding 110686203
Price to Book Ratio 4.00
Return on Assets (%) -2.47
Return on Capital (%) -3.56
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 486.00
Total Assets 4868.00
Total Liabilities 4868.00
Total Equity 1796.00
Share Outstanding 153400936
Price to Book Ratio 5.00
Return on Assets (%) -8.66
Return on Capital (%) -11.77
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 37.00
Total Assets 4732.00
Total Liabilities 4732.00
Total Equity 1753.00
Share Outstanding 144060153
Price to Book Ratio 1.26
Return on Assets (%) -9.84
Return on Capital (%) -13.82
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 207.00
Total Assets 5798.00
Total Liabilities 5798.00
Total Equity 2212.00
Share Outstanding 144060153
Price to Book Ratio 1.72
Return on Assets (%) -2.41
Return on Capital (%) -3.68
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 138.00
Total Assets 4895.00
Total Liabilities 4895.00
Total Equity 1606.00
Share Outstanding 110781153
Price to Book Ratio 2.84
Return on Assets (%) 12.11
Return on Capital (%) 18.42
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 157.48
Total Assets 4759.51
Total Liabilities 4759.51
Total Equity 994.62
Share Outstanding 110735003
Price to Book Ratio 1.92
Return on Assets (%) -4.85
Return on Capital (%) -9.65
Particulars MAR 2024 (Values in Cr)
Net Income -420.00
Cash from Operations 249.00
Cash from Investing -137.00
Cash from Financing 334.00
Net change in Cash 416.00
Free Cash Flow 308.00
Particulars MAR 2023 (Values in Cr)
Net Income -624.00
Cash from Operations 164.00
Cash from Investing -125.00
Cash from Financing -315.00
Net change in Cash -287.00
Free Cash Flow 206.00
Particulars MAR 2022 (Values in Cr)
Net Income -411.00
Cash from Operations 510.00
Cash from Investing -201.00
Cash from Financing -71.00
Net change in Cash 141.00
Free Cash Flow 628.00
Particulars MAR 2021 (Values in Cr)
Net Income 916.00
Cash from Operations -170.00
Cash from Investing 1470.00
Cash from Financing -1171.00
Net change in Cash 12.00
Free Cash Flow -89.00
Particulars MAR 2020 (Values in Cr)
Net Income -196.68
Cash from Operations 666.12
Cash from Investing -155.53
Cash from Financing -679.58
Net change in Cash -186.15
Free Cash Flow 696.77
Particulars MAR 2024 (Values in Cr)
Net Income -422.00
Cash from Operations 188.00
Cash from Investing -75.00
Cash from Financing 346.00
Net change in Cash 459.00
Free Cash Flow 190.00
Particulars MAR 2023 (Values in Cr)
Net Income -513.00
Cash from Operations 76.00
Cash from Investing -3.00
Cash from Financing -236.00
Net change in Cash -168.00
Free Cash Flow 76.00
Particulars MAR 2022 (Values in Cr)
Net Income -184.00
Cash from Operations -14.00
Cash from Investing -244.00
Cash from Financing 430.00
Net change in Cash 93.00
Free Cash Flow 38.00
Particulars MAR 2021 (Values in Cr)
Net Income 861.00
Cash from Operations -452.00
Cash from Investing 1014.00
Cash from Financing -480.00
Net change in Cash -29.00
Free Cash Flow -435.00
Particulars MAR 2020 (Values in Cr)
Net Income -338.32
Cash from Operations 222.01
Cash from Investing -16.15
Cash from Financing -273.97
Net change in Cash -68.61
Free Cash Flow 240.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1398.60
  • 26 Days 1342.70
  • 10 Days 1404.90
  • 50 Days 1233.90
  • 12 Days 1396.20
  • 100 Days 1122.10
  • 20 Days 1349.80
  • 200 Days 620.70
1404.40
PIVOT
First Resistance 1426.80
Second Resistance 1465.40
Third Resistance 1487.80
First Support 1365.80
Second Support 1343.40
Third Support 1304.80
RSI 61.50
MACD 53.52
Commodity Channel Index (CCI) 38.34
ADX 17.93
Williams % R -36.10

Over 1 Month

down

17.44

Over 3 Months

down

36.74

Over 6 Months

down

142.02

Over 1 Year

down

245.52

Over 3 Years

down

50.90

Over 5 Years

down

44.32

WOCKHARDT LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

WOCKHARDT LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
34.41
Promoter Holdings
49.09
FII
6.61
DII
9.88
Promoter Shares(Pledge Percentage)
36.1
Name Category Shares Shares%
Themisto Trustee Company Private Limited Shareholding of Promoter and Promoter Group 6.5244744E7 40.16
Pasithee Trustee Company Private Limited Shareholding of Promoter and Promoter Group 4420000.0 2.72
Ananke Trustee Company Private Limited Shareholding of Promoter and Promoter Group 3810693.0 2.35
Callirhoe Trustee Company Private Limited Shareholding of Promoter and Promoter Group 3112079.0 1.92
Estate Of Late Mr. Rakesh Jhunjhunwala Public Shareholding 2837005.0 1.75
3p India Equity Fund 1 Public Shareholding 2253682.0 1.39
Icici Prudential Elss Tax Saver Fund Public Shareholding 2183564.0 1.34
Hdfc Large And Mid Cap Fund Public Shareholding 1827087.0 1.12
Tata Mutual Fund - Tata Small Cap Fund Public Shareholding 1777133.0 1.09
Callirhoe Trustee Company Private Limite Shareholding of Promoter and Promoter Group 936751.0 0.58
Pasithee Trustee Company Private Limited Shareholding of Promoter and Promoter Group 650000.0 0.4
Habil F Khorakiwala Shareholding of Promoter and Promoter Group 597286.0 0.37
Murtaza Habil Khorakiwala Shareholding of Promoter and Promoter Group 294060.0 0.18
Huzaifa Habil Khorakiwala Shareholding of Promoter and Promoter Group 280800.0 0.17
Ananke Trustee Company Private Limited Shareholding of Promoter and Promoter Group 274530.0 0.17
Themisto Trustee Company Private Limited Shareholding of Promoter and Promoter Group 130000.0 0.08
Khorakiwala Holdings And Investments Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Palanpur Holdings And Investments Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Dartmour Holdings Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Zahabiya Khorakiwala Shareholding of Promoter and Promoter Group 0.0 0.0
Miqdad H Khorakiwala Shareholding of Promoter and Promoter Group 2340.0 0.0
Nafisa Habil Khorakiwala Shareholding of Promoter and Promoter Group 5565.0 0.0

WOCKHARDT LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2016-11-17 10.0 Interim 2016-11-19 Equity shares 2014-11-13 20.0 Interim 2014-11-15 Equity shares 2014-02-17 5.0 Interim 2 2014-02-19 Equity shares 2013-11-07 5.0 Interim 2013-11-08 Equity shares 2013-08-22 5.0 Final 2013-08-24 Equity shares 2008-04-17 2.5 Final 2008-04-22 Equity shares 2007-10-26 8.75 Interim 2007-10-29 Equity shares 2007-03-22 5.0 Interim 2007-03-23 Equity shares 2006-06-21 0.0 Final 2006-06-23 Equity shares
Ex-Date Ex-Bonus Ratio
2004-05-07 2004-04-28 1:2
Ex-Date Old FV NEW FV Record Date
2004-04-28 10.0 5.0 2004-05-07

Wockhardt Share Result Highlights 

Wockhardt's performance shows a 7.44% YoY sales growth in Q2 of this financial year, with revenue rising to ₹809 crore from ₹753 crore a year ago. It is also 70 crore higher than the first quarter of this year. However, the company reported a net loss of ₹16 crore, though this represents a significant 78% improvement in YoY profit, when compared to the same quarter last year. The operating profit reached ₹110 crore with a stable OPM of 14%, reflecting operational efficiency despite challenges.

Wockhardt Share Annual Reports

For FY24, Wockhardt’s revenue reached ₹2,798 crore, marking a 5.55% growth from ₹2,651 crore in FY23. However, net losses persisted, narrowing slightly to ₹472 crore compared to ₹621 crore the prior year. The company’s EPS stood at -₹30.18, reflecting ongoing challenges in profitability. Over the past three years, Wockhardt has shown a slight recovery in sales growth (1%), but negative returns on equity (-8% on average) highlight the need for operational improvements. These figures indicate Wockhardt’s slow but gradual turnaround amid a challenging pharmaceutical landscape. Interestingly, Wockhardt’s share price in the last 1 year period surged to 292%.

Wockhardt Share Dividend

Wockhardt did not declare any dividends for FY24, as it prioritised stabilising operations amid ongoing losses. The company’s dividend yield remains at 0%, reflecting its focus on reinvesting to address its financial challenges. Despite a 78% YoY improvement in Q2 profits, net losses and negative equity returns (-12% last year) underscore the difficulty of achieving dividend payouts. A noteworthy factor, here, is Wockhardt’s compounded profit growth of 16% over three years. 

About WOCKHARDT LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by WOCKHARDT LIMITED

Learn More About Stocks

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Additional FAQs

1. Who is the CEO of Wockhardt Ltd?

Dr. Habil Khorakiwala is the Founder and Chairman of Wockhardt Ltd, while Dr. Murtaza Khorakiwala is the company’s Managing Director.

 

2. When was Wockhardt Ltd established?

Wockhardt Ltd was established in 1967 and has grown into a global pharmaceutical and biotechnology company with a strong focus on innovation.

 

3. What factors influence the Wockhardt Share Price?

Wockhardt’s share price is influenced by factors such as product pipeline development, regulatory approvals, operational performance, and demand for its pharmaceutical offerings globally.

 

4. Is Wockhardt Ltd debt free?

No, Wockhardt Ltd is not debt free, as the company utilises financing to support its research, development, and expansion activities.

 

5. What is the CAGR of Wockhardt Share?

The CAGR of Wockhardt’s share is 5% over 10 years, 41% over 5 years, and 50% over 3 years.

 

6. How has the Wockhardt Share Price performed over the past year?

Over the past year, Wockhardt’s share price has seen a meteoric rise of 292%, driven by positive developments in its product offerings and improved financial performance.

 

Frequently Asked Questions

What is the Share Price of Wockhardt Ltd?

Answer Field

The share price of Wockhardt Ltd for NSE is ₹ 1396.95 and for BSE is ₹ 1396.75.

What is the Market Cap of Wockhardt Ltd?

Answer Field

The market cap of Wockhardt Ltd for NSE is ₹ 2,01,24.48 Cr. and for BSE is ₹ 2,01,21.60 Cr. as of now.

What is the 52 Week High and Low of Wockhardt Ltd?

Answer Field

The 52 Week High and Low of Wockhardt Ltd for NSE is ₹ 1466.95 and ₹ 376.45 and for BSE is ₹ 1467.00 and ₹ 376.50.

How to Buy Wockhardt Ltd share?

Answer Field

You can trade in Wockhardt Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Wockhardt Ltd?

Answer Field

The 1 year returns on the stock has been 245.52%.

What is the Current Share Price of Wockhardt Ltd?

Answer Field

Wockhardt Ltd share price is for NSE ₹ 1396.95 & for BSE ₹ 1396.75 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Wockhardt Ltd Share?

Answer Field

The market cap of Wockhardt Ltd for NSE ₹ 2,01,24.48 & for BSE ₹ 2,01,21.60 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Wockhardt Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Wockhardt Ltd share is -98.64.

What is the PB ratio of Wockhardt Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Wockhardt Ltd share is 170.16.

How to Buy Wockhardt Ltd Share?

Answer Field

You can trade in Wockhardt Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Wockhardt Ltd Share on Bajaj Broking App?

Answer Field

To buy Wockhardt Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Wockhardt Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader